Theophylline binding to plasma proteins in patients with chronic obstructive pulmonary disease. 1986

E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata

The binding of theophylline to plasma proteins was studied in samples from healthy adults at different pH values and drug concentrations and in samples from patients with chronic obstructive pulmonary disease (COPD). Binding determinations were performed by ultrafiltration and drug concentrations were measured by high performance liquid chromatography. Total plasma levels of theophylline did not influence the degree of the binding. The percentage of bound theophylline was positively correlated with pH both in vitro (r = 0.998, p less than 0.005) and in vivo (r = 0.579, p less than 0.005). Mean theophylline binding values in vivo (mean 56.3 +/- 12.5) and in vitro (mean 48.3 +/- 9.4) were significantly different. The increase in theophylline free levels detected in COPD patients was partially dependent on low pH values but the influence of other factors must also be considered. The therapeutic implications of altered theophylline binding are discussed.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo

Related Publications

E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
April 1990, International journal of clinical pharmacology, therapy, and toxicology,
E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
October 1986, The Journal of allergy and clinical immunology,
E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
January 1985, Therapeutic drug monitoring,
E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
December 1984, The New England journal of medicine,
E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
March 1988, The American review of respiratory disease,
E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
January 1992, Chest,
E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
March 1992, Medicina clinica,
E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
January 2002, The Cochrane database of systematic reviews,
E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
January 2005, Proceedings of the American Thoracic Society,
E P Calandre, and A Pérez de la Cruz, and N P Alferez, and E Moreno Carretero, and R Hinojosa, and G Vázquez Mata
February 1987, The American review of respiratory disease,
Copied contents to your clipboard!